<DOC>
	<DOCNO>NCT00929630</DOCNO>
	<brief_summary>Surgical treatment perianal fistula frequently affect fecal continence . Sphincter save technique like loose cut seton fistulectomy advancement endorectal flap advocate minimize risk sphincter injury , patient often complain prolonged healing period major discomfort . Furthermore , heal rate varies widely accord type fistula surgeon 's experience.In early '90s treatment perianal fistula autologous commercial fibrin glue suggest American FDA approve use marketing human fibrin glue 1998 . Since , several study evaluate effectiveness human fibrin glue treatment different type perianal fistula , report wide range success rate range 31 85 % . Primary aim study conduct prospective randomize trial evaluate effectiveness glue treatment perianal fistula compare classical seton treatment . Secondary aim compare postoperative faecal incontinence , postoperative anal pain , heal time length hospitalization .</brief_summary>
	<brief_title>Seton Glue Trans-sphincteric Anal Fistulas</brief_title>
	<detailed_description>Background : Fibrin glue treatment anal fistula propose minimize risk faecal incontinence acceptance coloproctologists still poor clear data literature lacking . We run prospective randomise trial compare commercial fibrin glue treatment classical seton treatment , take account heal rate , hospital stay , heal time , faecal incontinence postoperative pain . Patients Methods : 130 homogeneous patient trans-sphincteric anal fistula refer 7 Colorectal Units randomise undergo fibrin glue seton treatment . permanent heal fistula define absence discharge fistula heal secondary fistula orifice least 1 year follow . Post operative pain ( VAS scale ) hospital stay record compare two group</detailed_description>
	<mesh_term>Fistula</mesh_term>
	<mesh_term>Rectal Fistula</mesh_term>
	<mesh_term>Fibrin Tissue Adhesive</mesh_term>
	<criteria>medium high transsphincteric fistula cryptoglandular origin , previous treatment Crohn 's disease anal abscess complex fistula ( horseshoe type multiple secondary tract ) immunosuppression diabetes , anal fissure pregnancy anticoagulant treatment , allergic reaction bioglue component .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>fibrin glue</keyword>
	<keyword>transsphincteric anal fistula</keyword>
	<keyword>seton</keyword>
	<keyword>incontinence</keyword>
	<keyword>prospective randomise trial</keyword>
</DOC>